Disclosure Information
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.
Ineligible company
The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.
Financial Relationships
Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.
Conflict of Interest
Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.
Planning Committee Disclosures
Andrew Kastenmeier, MD, FACS - Planner and Course Co-chair, for this educational event, has financial relationship(s) with: 1) Gore as an educator and received an honorarium.
David E. Meyer, MD, FACS - Module Chair and Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose.
Laura J. Moore, MD, FACS - Planner, Module Chair, and Course Chair, for this educational event, has financial relationship(s) with: 1) Frontline Medical Technologies as a Chair for the Clinical Adv. Board and received stock. 2) Decisio Health Inc is a Clinical Co-founder and received stock.
Speakers / Faculty Disclosures
Megan L. Brenner, MD, FACS - Faculty, for this educational event, has financial relationship(s) with: 1) Up to Date as a speaker and received royalties.
Matthew Harting, MD, FACS - Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose.
Kyle J. Kalkwarf, MD, FACS - Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose.
David E. Meyer, MD, FACS - Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose.
Laura J. Moore, MD, FACS - Faculty for this educational event, has financial relationship(s) with: 1) Frontline Medical Technologies as a Chair for the Clinical Adv. Board and received stock. 2) Decisio Health Inc is a Clinical Co-founder and received stock.
Rachel S. Morris, MD, FACS - Faculty, for this educational event, has financial relationship(s) with: 1) Advanced Trauma Analytics as CEO.
Melissa Stewart, MD, FACS - Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose.
Dia Waguespack, MD - Faculty, for this educational event, has financial relationship(s) with: 1) Amgen as a speaker and received consulting fees. 2) Davita as a consultant and received stock.
Shihuan K. Wang, MD, RPVI - Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose.
Catherine M. Wittgen, MD, FACS - Faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose.
